Treating Blood Cancers  Por  arte de portada

Treating Blood Cancers

De: The Leukemia & Lymphoma Society
  • Resumen

  • LLS Podcast Series for Professionals
    2019 Treating Blood Cancers Podcast Series - The Leukemia & Lymphoma Society
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Exploring Survivorship Needs of Older Adults
    Jul 8 2024
    Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY Recorded on April 16, 2024 Cesar Rodriguez, MD Associate Professor of Medicine, Tisch Cancer Institute Clinical Director, Multiple Myeloma Center of Excellence Mount Sinai Hospital New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the healthcare provider’s role in survivorship care for older adults. Dr. Rodriguez explores the unique challenges of managing long-term and late effects of treatment and coordinating follow-up care. He also shares valuable perspectives on the impact of language and cultural considerations, along with the importance of caregiver support for older adult survivors. Listen in today! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
    Más Menos
    34 m
  • Strategic Approaches to Pediatric and AYA Survivorship Care
    Jun 20 2024
    Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA Recorded on April 4, 2024 Karen E. Effinger, MD, MS Associate Professor of Pediatrics Emory University School of Medicine Co-Director, Survivor Program Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta Atlanta, GA In this episode, Dr. Karen Effinger from Children’s Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors! This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.
    Más Menos
    29 m
  • Insights and Updates on Navigating the AML Landscape
    Jun 7 2024
    Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX Recorded on March 28, 2024 Hagop M. Kantarjian, M.D. Professor and Chairman, Department of Leukemia Samsung Distinguished University Chair in Cancer Medicine MD Anderson Cancer Center, University of Texas Houston, TX Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!
    Más Menos
    35 m

Lo que los oyentes dicen sobre Treating Blood Cancers

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.